Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene and VHL-haplotype analysis in patients with presumable congenital erythrocytosis

Haematologica

Volumn 90, Issue 1, 2005, Pages 19-24

  Cario, Holger ^a   Schwarz, Klaus ^a,b   Jorch, Norbert ^c   Kyank, Ulrike ^d   Petrides, Petro E ^e   Schneider, Dominik T ^f   Uhle, Renate ^g   Debatin, Klaus Michael ^a   Kohne, Elisabeth ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Institute for Clinical Transfusion Medicine and Immunogenetics Ulm   (Germany)

^c Children's Hospital   (Germany)

^d ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^e Hematology Oncology Center   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g Hematology Oncology Center Magdeburg   (Germany)

Author keywords

Congenital erythrocytosis; Polycythemia; Von Hippel Lindau gene

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHUVASH TYPE MUTATION; CLINICAL ARTICLE; ERYTHROCYTOSIS; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; TUMOR SUPPRESSOR GENE; VHL GENE;

ADOLESCENT; ADULT; ALLELES; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; ERYTHROPOIETIN; FAMILY HEALTH; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HAPLOTYPES; HIPPEL-LINDAU DISEASE; HUMANS; MIDDLE AGED; POINT MUTATION; POLYCYTHEMIA; POLYMERASE CHAIN REACTION;

EID: 13244281831     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Prchal JT. Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders. Semin Hematol 2001; 36:10-20.
2. Charache S, Weatherall DJ, Clegg JB. Polycythemia associated with a hemoglobinopathy. J Clin Invest 1966;45:813-22.
3. Wajcman H, Galacteros F. Abnormal hemoglobins with high oxygen affinity and erythrocytosis. Hematol Cell Ther 1996;38:305-12.
4. Cartier P, Labie D, Leroux JP, Najman A, Demaugre F. [Familial diphosphoglycerate mutase deficiency: hematological and biochemical study]. Nouv Rev Fr Hematol 1972;12:269-87.
5. Rosa R, Blouquit Y, Calvin MC, Prome D, Prome JC, Rosa J. Isolation, characterization, and structure of a mutant 89 Arg→Cys bisphosphoglycerate mutase. Implication of the active site in the mutation. J Biol Chem 1989;264:7837-43.
6. Pastore YD, Jelinek J, Ang S, Guan Y, Liu E, Jedlickova K, et al. Mutations in the VHL gene in sporadic apparently congenital polycythemia. Blood 2003;101:1591-5.
7. Sergeyeva A, Gordeuk VR, Tokarev YN, Sokol L, Prchal JF, Prchal JT. Congenital polycythemia in Chuvashia. Blood 1997; 89:2148-54.
8. Ang SO, Chen H, Gordeuk VR, Sergueeva AI, Polyakova LA, Miasnikova GX et al. Endemic polycythemia in Russia: mutation in the VHL gene. Blood Cells Mol Dis 2002;28:57-62.
9. Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan Y, et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 2002; 32:614-21.
10. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271-5.
11. Huang LE, Bunn HF. Hypoxia-inducible factor and its biomedical relevance. J Biol Chem 2003;278:19575-8.
12. Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 2001;7:345-50.
13. Pastore Y, Jedlickova K, Guan Y, Liu E, Fahner J. Hasle H, et al. Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia. Am J Hum Genet 2003;73:412-9.
14. Percy MJ, McMullin MF, Jowitt SN, Potter M. Treacy M, Watson WH, et al. Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry. Blood 2003;102:1097-9.
15. Liu E, Percy MJ, Amos CI, Guan Y, Shete S, Stockton DW. et al. The worldwide distribution of the VHL 598C→T mutation indicates a single founding event. Blood 2004;103:1937-40.
16. Polyakova LA. Familial erythrocytosis among inhabitants of the Chuvash ASSR. Problemi gematologii i perilivaniya krovi 1974;10:30-6.
17. Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr, Pavletich NP. Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling. Science 2002;296: 1886-9.
18. Hon WC, Wilson MI, Harlos K, Claridge TD, Schofield CJ, Pugh CW, et al. Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL. Nature 2002;417:975-8.